219 related articles for article (PubMed ID: 24944166)
1. Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging.
Chakravarty R; Valdovinos HF; Chen F; Lewis CM; Ellison PA; Luo H; Meyerand ME; Nickles RJ; Cai W
Adv Mater; 2014 Aug; 26(30):5119-23. PubMed ID: 24944166
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free
Madru R; Budassi M; Benveniste H; Lee H; Smith SD; Schlyer DJ; Vaska P; Knutsson L; Strand SE
Cancer Biother Radiopharm; 2018 Aug; 33(6):213-220. PubMed ID: 30036073
[TBL] [Abstract][Full Text] [Related]
3. A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging.
Gholami YH; Yuan H; Wilks MQ; Maschmeyer R; Normandin MD; Josephson L; El Fakhri G; Kuncic Z
Int J Nanomedicine; 2020; 15():1253-1266. PubMed ID: 32161456
[TBL] [Abstract][Full Text] [Related]
4. Fast synthesis and bioconjugation of (68) Ga core-doped extremely small iron oxide nanoparticles for PET/MR imaging.
Pellico J; Ruiz-Cabello J; Saiz-Alía M; Del Rosario G; Caja S; Montoya M; Fernández de Manuel L; Morales MP; Gutiérrez L; Galiana B; Enríquez JA; Herranz F
Contrast Media Mol Imaging; 2016 May; 11(3):203-10. PubMed ID: 26748837
[TBL] [Abstract][Full Text] [Related]
5. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT
Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160
[TBL] [Abstract][Full Text] [Related]
6. Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents.
Bouziotis P; Psimadas D; Tsotakos T; Stamopoulos D; Tsoukalas C
Curr Top Med Chem; 2012; 12(23):2694-702. PubMed ID: 23339765
[TBL] [Abstract][Full Text] [Related]
7. Design, Properties, and In Vivo Behavior of Super-paramagnetic Persistent Luminescence Nanohybrids.
Teston E; Lalatonne Y; Elgrabli D; Autret G; Motte L; Gazeau F; Scherman D; Clément O; Richard C; Maldiney T
Small; 2015 Jun; 11(22):2696-704. PubMed ID: 25653090
[TBL] [Abstract][Full Text] [Related]
8. Development of a multimodal imaging probe by encapsulating iron oxide nanoparticles with functionalized amphiphiles for lymph node imaging.
Yang BY; Moon SH; Seelam SR; Jeon MJ; Lee YS; Lee DS; Chung JK; Kim YI; Jeong JM
Nanomedicine (Lond); 2015 Jul; 10(12):1899-910. PubMed ID: 26139125
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent.
Glaus C; Rossin R; Welch MJ; Bao G
Bioconjug Chem; 2010 Apr; 21(4):715-22. PubMed ID: 20353170
[TBL] [Abstract][Full Text] [Related]
11. Chelator-free synthesis of a dual-modality PET/MRI agent.
Chen F; Ellison PA; Lewis CM; Hong H; Zhang Y; Shi S; Hernandez R; Meyerand ME; Barnhart TE; Cai W
Angew Chem Int Ed Engl; 2013 Dec; 52(50):13319-23. PubMed ID: 24166933
[No Abstract] [Full Text] [Related]
12. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer.
Thomas R; Park IK; Jeong YY
Int J Mol Sci; 2013 Jul; 14(8):15910-30. PubMed ID: 23912234
[TBL] [Abstract][Full Text] [Related]
13. Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study.
Karageorgou MA; Vranješ-Djurić S; Radović M; Lyberopoulou A; Antić B; Rouchota M; Gazouli M; Loudos G; Xanthopoulos S; Sideratou Z; Stamopoulos D; Bouziotis P; Tsoukalas C
Contrast Media Mol Imaging; 2017; 2017():6951240. PubMed ID: 29445321
[TBL] [Abstract][Full Text] [Related]
14. Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles.
Su T; Wang YB; Han D; Wang J; Qi S; Gao L; Shao YH; Qiao HY; Chen JW; Liang SH; Nie YZ; Li JY; Cao F
Theranostics; 2017; 7(19):4791-4804. PubMed ID: 29187904
[No Abstract] [Full Text] [Related]
15. Chelator-Free Radiolabeling of SERRS Nanoparticles for Whole-Body PET and Intraoperative Raman Imaging.
Wall MA; Shaffer TM; Harmsen S; Tschaharganeh DF; Huang CH; Lowe SW; Drain CM; Kircher MF
Theranostics; 2017; 7(12):3068-3077. PubMed ID: 28839464
[TBL] [Abstract][Full Text] [Related]
16. Instant labeling of therapeutic cells for multimodality imaging.
Nejadnik H; Jung KO; Theruvath AJ; Kiru L; Liu A; Wu W; Sulchek T; Pratx G; Daldrup-Link HE
Theranostics; 2020; 10(13):6024-6034. PubMed ID: 32483435
[TBL] [Abstract][Full Text] [Related]
17. Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for
Zhan Y; Ehlerding EB; Shi S; Graves SA; Goel S; Engle JW; Liang J; Cai W
J Biomed Nanotechnol; 2018 May; 14(5):900-909. PubMed ID: 29883560
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agent.
Torres Martin de Rosales R; Tavaré R; Paul RL; Jauregui-Osoro M; Protti A; Glaria A; Varma G; Szanda I; Blower PJ
Angew Chem Int Ed Engl; 2011 Jun; 50(24):5509-13. PubMed ID: 21544908
[No Abstract] [Full Text] [Related]
19. Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences.
Fowler KJ; McConathy J; Narra VR
J Magn Reson Imaging; 2014 Feb; 39(2):259-68. PubMed ID: 24436150
[TBL] [Abstract][Full Text] [Related]
20. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
